Federico Ricci Selected Research

Federico Ricci Research Topics

Disease

15	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 01/2010
9	Choroidal Neovascularization 01/2022 - 01/2010
4	Inflammation (Inflammations) 05/2021 - 01/2013
3	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 05/2022 - 01/2017
3	Vision Disorders (Hemeralopia) 04/2019 - 09/2007
3	Macular Edema 01/2019 - 01/2015
2	Ganglion Cysts (Ganglion) 05/2022 - 01/2017
2	Blindness (Hysterical Blindness) 02/2022 - 07/2020
2	Vascular Diseases (Vascular Disease) 05/2021 - 02/2018
2	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2019 - 02/2018
2	Retinal Diseases 02/2018 - 01/2007
2	Endophthalmitis (Ophthalmia) 01/2016 - 11/2008
2	Angioid Streaks 06/2010 - 06/2010
1	Hyperpigmentation 03/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Cysts 01/2020
1	Pathologic Neovascularization 02/2018
1	Retinal Vein Occlusion 02/2018
1	Arteritis 01/2017
1	Atrophy 10/2014
1	Scotoma (Scintillating Scotoma) 04/2014
1	Acute zonal occult outer retinopathy 04/2014
1	Multifocal Choroiditis 04/2014
1	Neurosyphilis (General Paresis of the Insane) 02/2014
1	Chorioretinitis 02/2014
1	Syphilis 02/2014
1	Polypoidal Choroidal Vasculopathy 07/2012
1	Hemorrhage 07/2012
1	Glaucoma 01/2012
1	Herpes Simplex 04/2010
1	Keratitis 04/2010
1	Infections 04/2010
1	Colonic Neoplasms (Colon Cancer) 11/2009
1	Neoplasms (Cancer) 11/2009
1	Wounds and Injuries (Trauma) 11/2008
1	Corneal Ulcer 11/2008
1	Ulcer 11/2008
1	Corneal Diseases (Corneal Disease) 01/2006
1	Cataract (Cataracts) 12/2004

Drug/Important Bio-Agent (IBA)

12	Retinaldehyde (Retinal)IBA 05/2022 - 11/2008
8	Ranibizumab (Lucentis)FDA Link 01/2022 - 06/2010
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2021 - 07/2012
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2009
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2017 - 04/2014
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2014 - 06/2010
2	afliberceptIBA 11/2019 - 11/2017
2	SteroidsIBA 01/2019 - 01/2016
1	Monophenol Monooxygenase (Tyrosinase)IBA 03/2022
1	Biosimilar PharmaceuticalsIBA 01/2022
1	AngiopoietinsIBA 05/2021
1	Vascular Endothelial Growth FactorsIBA 01/2021
1	N-acetyltryptophanamide (NATA)IBA 11/2019
1	MicroRNAs (MicroRNA)IBA 03/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Prostaglandins FIBA 02/2018
1	Oxygen (Dioxygen)IBA 02/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2018
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2017
1	Platelet-Derived Growth FactorIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Bevacizumab (Avastin)FDA Link 01/2016
1	Adalimumab (Humira)FDA Link 04/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2014
1	Penicillin G (Benzylpenicillin)FDA LinkGeneric 02/2014
1	Interleukin-8 (Interleukin 8)IBA 01/2013
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 06/2010
1	Verteporfin (Visudyne)FDA Link 06/2010
1	Triamcinolone (Aristocort)FDA Link 06/2010
1	Pharmaceutical PreparationsIBA 01/2010
1	pegaptanib (Macugen)FDA Link 01/2010
1	Protein Isoforms (Isoforms)IBA 11/2009
1	ClusterinIBA 11/2009
1	GATIBA 01/2006
1	Phosmet (Prolate)IBA 12/2004

Therapy/Procedure

9	Therapeutics 05/2021 - 01/2007
3	Intravitreal Injections 01/2016 - 07/2012
3	Photochemotherapy (Photodynamic Therapy) 10/2014 - 06/2010
2	Retreatment 11/2019 - 04/2019
2	Telescopes 01/2012 - 09/2007
1	Lasers (Laser) 02/2018
1	Precision Medicine 01/2018
1	Aftercare (After-Treatment) 02/2014
1	Penetrating Keratoplasty 04/2010
1	Injections 01/2010
1	Vitrectomy 11/2008